Alan/B-PERSON Seelenfreund/I-PERSON ,/O 52/O years/O old/O ,/O was/O named/O chairman/O of/O this/O processor/O of/O prescription/O claims/O ,/O succeeding/O Thomas/B-PERSON W./I-PERSON Field/I-PERSON Jr./I-PERSON ,/O 55/O ,/O who/O resigned/O last/O month/O ./O
Mr./O Field/B-PERSON also/O had/O been/O chairman/O of/O McKesson/B-ORG Corp./I-ORG ,/O resigning/O that/O post/O after/O a/O dispute/O with/O the/O board/O over/O corporate/O strategy/O ./O
Mr./O Seelenfreund/B-PERSON is/O executive/O vice/O president/O and/O chief/O financial/O officer/O of/O McKesson/B-ORG and/O will/O continue/O in/O those/O roles/O ./O
PCS/B-ORG also/O named/O Rex/B-PERSON R./I-PERSON Malson/I-PERSON ,/O 57/O ,/O executive/O vice/O president/O at/O McKesson/B-ORG ,/O as/O a/O director/O ,/O filling/O the/O seat/O vacated/O by/O Mr./O Field/B-PERSON ./O
Messrs./O Malson/B-PERSON and/O Seelenfreund/B-PERSON are/O directors/O of/O McKesson/B-ORG ,/O which/O has/O an/O 86/O %/O stake/O in/O PCS/B-ORG ./O
